• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Neogenomics Inc (NQ: NEO )

    15.46 +0.53 (+3.55%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Neogenomics Inc

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    11 12 Next >
    NeoGenomics Reports Third Quarter 2024 Results
    From NeoGenomics, Inc.
    Via Business Wire
    NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test
    From NeoGenomics, Inc.
    Via Business Wire
    NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024
    From NeoGenomics, Inc.
    Via Business Wire
    Expert Ratings For NeoGenomics
    Via Benzinga
    NEO Stock Earnings: NeoGenomics Beats Revenue for Q2 2024
    NEO stock results show that NeoGenomics beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    NeoGenomics Earnings Analysis: Q1 Recap
    Via Benzinga
    NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia
    From NeoGenomics, Inc.
    Via Business Wire
    NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation
    From NeoGenomics, Inc.
    Via Business Wire
    NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
    From NeoGenomics, Inc.
    Via Business Wire
    NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
    From NeoGenomics, Inc.
    Via Business Wire
    Where NeoGenomics Stands With Analysts
    Via Benzinga
    What 6 Analyst Ratings Have To Say About NeoGenomics
    Via Benzinga
    Shake Shack And Lumen Tech Are Among Top 7 Mid Cap Stocks With Max Gains Last Week (July 28-August 3): Are The Others In Your Portfolio?
    Seven mid-cap stocks that performed well last week: LUMN, SHAK, PSN, CWAN, RGEN, FTDR, and NEO. Check if they're in your portfolio! 
    Via Benzinga
    Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    NeoGenomics Reports Second Quarter 2024 Results
    From NeoGenomics, Inc.
    Via Business Wire
    NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024
    From NeoGenomics, Inc.
    Via Business Wire
    Fort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer Month
    From NeoGenomics, Inc.
    Via Business Wire
    NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management
    From NeoGenomics, Inc.
    Via Business Wire
    NEO Stock Earnings: NeoGenomics Beats EPS, Beats Revenue for Q1 2024
    NEO stock results show that NeoGenomics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    NeoGenomics Reports First Quarter 2024 Results
    From NeoGenomics, Inc.
    Via Business Wire
    NeoGenomics Announces Senior Leadership Promotions
    From NeoGenomics, Inc.
    Via Business Wire
    NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
    From NeoGenomics, Inc.
    Via Business Wire
    NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting
    From NeoGenomics, Inc.
    Via Business Wire
    NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report
    From NeoGenomics, Inc.
    Via Business Wire
    Earnings Scheduled For March 15, 2024
    Companies Reporting Before The Bell • EHang Holdings (NASDAQ:EH) is expected to report quarterly loss at $0.10 per share on revenue of $7.83 million. 
    Via Benzinga
    NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference
    From NeoGenomics, Inc.
    Via Business Wire
    Goldman Sachs Maintains Buy Rating for NeoGenomics: Here's What You Need To Know
    Via Benzinga
    NeoGenomics Stock Surged But Technicals Point To A Pullback
    NeoGenomics stock price popped sharply this week after the company published strong financial results. It soared to a high of $16.50, its highest point since December 29th. It has soared by more than... 
    Via Talk Markets
    Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    11 12 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.